Paper17409451
Active induction of tumor-specific IgE antibodies by oral mimotope vaccination.
Riemer AB and 7 others. Cancer Res, 2007. Cited by 35 papers, by iCite.
Cite this record
ConductScience Library. Active induction of tumor-specific IgE antibodies by oral mimotope vaccination. Papers, record 17409451. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17409451
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antibodies, Neoplasm | Major topic |
| Breast Neoplasms | Major topic |
| Cancer Vaccines | Major topic |
| Immunoglobulin E | Major topic |
| Animals | |
| Antibodies, Monoclonal | |
| Antibodies, Monoclonal, Humanized | |
| Antibody Specificity | |
| Cell Line, Tumor | |
| Cytotoxicity, Immunologic | |
| Epitopes | |
| Humans | |
| Rats | |
| Erb-b2 Receptor Tyrosine Kinases | |
| Trastuzumab |
Source PubMed
Cited by24
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 35 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42738328 | Skin AllergoOncology: A Framework for Decoding the Context-Dependent Functions of the IgE-FcεRI Axis in Cutaneous Malignancies. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42738328 | PubMed |
| 38389406 | The type 2 inflammatory response favors recognition of tumor antigens by IgE in breast cancer. | Cancer Rep (Hoboken) | 2024 | https://conductscience.org/library/papers/38389406 | PubMed |
| 37185332 | Anti-cancer pro-inflammatory effects of an IgE antibody targeting the melanoma-associated antigen chondroitin sulfate proteoglycan 4. | Nat Commun | 2023 | https://conductscience.org/library/papers/37185332 | PubMed |
| 32273212 | Antibodies specific for disease-associated antigens (DAA) expressed in non-malignant diseases reveal potential new tumor-associated antigens (TAA) for immunotherapy or immunoprevention. | Semin Immunol | 2020 | https://conductscience.org/library/papers/32273212 | PubMed |
| 31544825 | IgE Antibodies: From Structure to Function and Clinical Translation. | Antibodies (Basel) | 2019 | https://conductscience.org/library/papers/31544825 | PubMed |
| 29467889 | Serum immunoglobulin E response as a marker for unfavorable prognosis following cholesteryl pullulan-MAGE A4 vaccination. | Oncol Lett | 2018 | https://conductscience.org/library/papers/29467889 | PubMed |
| 28105158 | Time-dependent transition of the immunoglobulin G subclass and immunoglobulin E response in cancer patients vaccinated with cholesteryl pullulan-melanoma antigen gene-A4 nanogel. | Oncol Lett | 2016 | https://conductscience.org/library/papers/28105158 | PubMed |
| 28096174 | Anti-Folate Receptor-α IgE but not IgG Recruits Macrophages to Attack Tumors via TNFα/MCP-1 Signaling. | Cancer Res | 2017 | https://conductscience.org/library/papers/28096174 | PubMed |
| 28032353 | AllergoOncology - the impact of allergy in oncology: EAACI position paper. | Allergy | 2017 | https://conductscience.org/library/papers/28032353 | PubMed |
| 27622022 | Proof of concept study with an HER-2 mimotope anticancer vaccine deduced from a novel AAV-mimotope library platform. | Oncoimmunology | 2016 | https://conductscience.org/library/papers/27622022 | PubMed |
| 26451312 | Elevated IgG4 in patient circulation is associated with the risk of disease progression in melanoma. | Oncoimmunology | 2015 | https://conductscience.org/library/papers/26451312 | PubMed |
| 25553797 | IgE immunotherapy against cancer. | Curr Top Microbiol Immunol | 2015 | https://conductscience.org/library/papers/25553797 | PubMed |
| 24484217 | Identification of anti-CD98 antibody mimotopes for inducing antibodies with antitumor activity by mimotope immunization. | Cancer Sci | 2014 | https://conductscience.org/library/papers/24484217 | PubMed |
| 24423620 | IgE immunotherapy: a novel concept with promise for the treatment of cancer. | MAbs | 2014 | https://conductscience.org/library/papers/24423620 | PubMed |
| 22855780 | Association between prediagnostic IgE levels and risk of glioma. | J Natl Cancer Inst | 2012 | https://conductscience.org/library/papers/22855780 | PubMed |
| 22692757 | Using the allergic immune system to target cancer: activity of IgE antibodies specific for human CD20 and MUC1. | Cancer Immunol Immunother | 2012 | https://conductscience.org/library/papers/22692757 | PubMed |
| 22674055 | Recombinant IgE antibody engineering to target EGFR. | Cancer Immunol Immunother | 2012 | https://conductscience.org/library/papers/22674055 | PubMed |
| 22527244 | The roles of mast cells in anticancer immunity. | Cancer Immunol Immunother | 2012 | https://conductscience.org/library/papers/22527244 | PubMed |
| 22382876 | Induction of IgM, IgA and IgE antibodies in colorectal cancer patients vaccinated with a recombinant CEA protein. | J Clin Immunol | 2012 | https://conductscience.org/library/papers/22382876 | PubMed |
| 20126404 | The high affinity IgE receptor Fc epsilonRI is expressed by human intestinal epithelial cells. | PLoS One | 2010 | https://conductscience.org/library/papers/20126404 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| IGHE | 3497 | PubTator's text mining | https://conductscience.org/library/genes/3497 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/17409451
GET https://conductscience.org/api/papers/v1/17409451/cited_by?page=2